These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 2166829)

  • 1. The glycoprotein products of varicella-zoster virus gene 14 and their defective accumulation in a vaccine strain (Oka).
    Kinchington PR; Ling P; Pensiero M; Moss B; Ruyechan WT; Hay J
    J Virol; 1990 Sep; 64(9):4540-8. PubMed ID: 2166829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcription mapping of glycoprotein I (gpI) and gpIV of varicella-zoster virus and immunological analysis of the gpI produced in cells infected with the recombinant vaccinia virus.
    Kato T; Kitamura K; Hayakawa Y; Takahashi M; Kojima A; Sato S; Yamanishi K
    Microbiol Immunol; 1989; 33(4):299-312. PubMed ID: 2549343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New method of differentiating wild-type varicella-zoster virus (VZV) strains from Oka varicella vaccine strain by VZV ORF 6-based PCR and restriction fragment length polymorphism analysis.
    Takayama M; Takayama N
    J Clin Virol; 2004 Feb; 29(2):113-9. PubMed ID: 14747030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutralizing antibodies induced by recombinant vaccinia virus expressing varicella-zoster virus gpIV.
    Vafai A; Yang WN
    J Virol; 1991 Oct; 65(10):5593-6. PubMed ID: 1654454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenicity in mice of varicella-zoster virus glycoprotein I expressed by a vaccinia virus-varicella-zoster virus recombinant.
    Ludvíková V; Kunke D; Hamsíková E; Kutinová L; Vonka V
    J Gen Virol; 1991 Jun; 72 ( Pt 6)():1445-9. PubMed ID: 1646285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Open reading frame S/L of varicella-zoster virus encodes a cytoplasmic protein expressed in infected cells.
    Kemble GW; Annunziato P; Lungu O; Winter RE; Cha TA; Silverstein SJ; Spaete RR
    J Virol; 2000 Dec; 74(23):11311-21. PubMed ID: 11070031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutralization epitope of varicella zoster virus on native viral glycoprotein gp118 (VZV glycoprotein gpIII).
    Montalvo EA; Grose C
    Virology; 1986 Mar; 149(2):230-41. PubMed ID: 2418586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunity in strain 2 guinea-pigs inoculated with vaccinia virus recombinants expressing varicella-zoster virus glycoproteins I, IV, V or the protein product of the immediate early gene 62.
    Lowry PW; Solem S; Watson BN; Koropchak CM; Thackray HM; Kinchington PR; Ruyechan WT; Ling P; Hay J; Arvin AM
    J Gen Virol; 1992 Apr; 73 ( Pt 4)():811-9. PubMed ID: 1321876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of neutralizing antibody against varicella-zoster virus (VZV) by VZV gp3 and cross-reactivity between VZV gp3 and herpes simplex viruses gB.
    Kitamura K; Namazue J; Campo-Vera H; Ogino T; Yamanishi K
    Virology; 1986 Feb; 149(1):74-82. PubMed ID: 2418583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A detailed analysis of transcripts mapping to varicella zoster virus gene 14 (glycoprotein V).
    Ling P; Kinchington PR; Ruyechan WT; Hay J
    Virology; 1991 Oct; 184(2):625-35. PubMed ID: 1653492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and expression of a human cytomegalovirus glycoprotein with homology to the Epstein-Barr virus BXLF2 product, varicella-zoster virus gpIII, and herpes simplex virus type 1 glycoprotein H.
    Cranage MP; Smith GL; Bell SE; Hart H; Brown C; Bankier AT; Tomlinson P; Barrell BG; Minson TC
    J Virol; 1988 Apr; 62(4):1416-22. PubMed ID: 2831402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of varicella-zoster virus glycoprotein I in cells infected with a vaccinia virus recombinant.
    Cabirac G; Gilden D; Wellish M; Vafai A
    Virus Res; 1988 May; 10(2-3):205-13. PubMed ID: 2842971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of antibody against in vitro translation products encoded by varicella-zoster virus glycoprotein genes.
    Vafai A; Wellish M; Wroblewska Z; Cisco M; Gilden D
    Virus Res; 1987 Jun; 7(4):325-33. PubMed ID: 3039752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absence of varicella-zoster virus (VZV) glycoprotein V does not alter growth of VZV in vitro or sensitivity to heparin.
    Cohen JI; Seidel KE
    J Gen Virol; 1994 Nov; 75 ( Pt 11)():3087-93. PubMed ID: 7964618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three major glycoprotein genes of varicella-zoster virus whose products have neutralization epitopes.
    Keller PM; Neff BJ; Ellis RW
    J Virol; 1984 Oct; 52(1):293-7. PubMed ID: 6207311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of virus transcription during lytic infection of the Oka parental and vaccine strains of Varicella-Zoster virus.
    Cohrs RJ; Gilden DH; Gomi Y; Yamanishi K; Cohen JI
    J Virol; 2006 Mar; 80(5):2076-82. PubMed ID: 16474115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression in recombinant vaccinia virus of the equine herpesvirus 1 gene encoding glycoprotein gp13 and protection of immunized animals.
    Guo PX; Goebel S; Davis S; Perkus ME; Languet B; Desmettre P; Allen G; Paoletti E
    J Virol; 1989 Oct; 63(10):4189-98. PubMed ID: 2550665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiation of oka varicella vaccine strain from wild varicella-zoster virus strains isolated from vaccinees and household contact.
    Shiraki K; Horiuchi K; Asano Y; Yamanishi K; Takahashi M
    J Med Virol; 1991 Feb; 33(2):128-32. PubMed ID: 1675658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Characterization analysis of gM, gL genes of varicella zoster virus in six provinces of China].
    Mou JJ; Qi MY; Li CS; Zheng HY; Chen M; Zhou JH; He JL; Xu WW; Xu ST; Xu XG
    Zhonghua Yu Fang Yi Xue Za Zhi; 2018 Apr; 52(4):419-423. PubMed ID: 29614611
    [No Abstract]   [Full Text] [Related]  

  • 20. Analysis of varicella zoster virus attenuation by evaluation of chimeric parent Oka/vaccine Oka recombinant viruses in skin xenografts in the SCIDhu mouse model.
    Zerboni L; Hinchliffe S; Sommer MH; Ito H; Besser J; Stamatis S; Cheng J; Distefano D; Kraiouchkine N; Shaw A; Arvin AM
    Virology; 2005 Feb; 332(1):337-46. PubMed ID: 15661165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.